Effect and mechanism of microRNA-155 on cell biological behavior of thyroid papillary carcinoma cells
10.3760/cma.j.issn.115807-20190618-00114
- VernacularTitle:MicroRNA-155对甲状腺乳头状癌细胞生物学行为的作用及机制研究
- Author:
Zhaoshu WU
1
;
Wei HAN
;
Yue CAO
;
Mengdi CUI
;
Yue YANG
;
Lang ZHOU
;
Min LI
;
Gang WANG
;
Dongchen LU
;
Honglin FAN
;
Kai LU
Author Information
1. 南京中医药大学附属南京市中医院普外科 210000
- From:Chinese Journal of Endocrine Surgery
2020;14(2):139-143
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the role of miR-155 in the differentiation of papillary thyroid carcinoma (PTC) cells, and to explore the possible mechanism.Methods:Human miR-155 analogues were constructed and transfected into PTC BCPAP cells in vitro. CCK8 test and Transwell test were used to observe the changes of cell proliferation and invasiveness. The miR-155 was transfected into BCPAP cells in vitro and the protein background and phosphorylation expression of MAPK pathway were detected by Western blot. ERK pathway inhibitor U0126 was given to observe whether it could reverse the abnormal proliferation and invasion of thyroid cancer cells caused by over-expression of miR-155.Results:The proliferation of BCPAP cells was detected by CCK8 test 48 hours after overexpression of miR-155, and the invasiveness of thyroid cancer cells was significantly enhanced by Transwell test 48 hours after overexpression of miR-155 ( P<0.05) ; Western blot method found that the expression of JNK, ERK and p38 in MAPK signal pathway was significantly up-regulated ( P<0.05) . At the same time, the expression of p-ERK protein in the cells was increased significantly ( P<0.05) . The expression of p-ERK in the cells treated with ERK pathway inhibitor U0126 and miR-155 was significantly lower than that in the miR-155 group ( P<0.05) . By detecting the proliferation and invasion of cells in each group, we found that the U0126 could reverse the proliferation and invasion promoting effect caused by miR-155. Conclusion:miR-155 can promote the proliferation and invasion of PTC BCPAP cells by activating the ERK pathway of MAPK pathway, which provides a potential target for the treatment of thyroid cancer.
